SCHEMBL3846941

SCHEMBL3846941

O=c1[nH]c2cc(F)ccc2cc1CCN1CC[CH]CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 5/20 0.47
PARP1 P09874 2/20 0.47
DAO P14920 1/20 0.47
DDO Q99489 1/20 0.47
KDM4E B2RXH2 7/20 0.42
TSHR P16473 3/20 0.42
PKM P14618 1/20 0.42
MPO P05164 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
LMNA P02545 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
SLC6A3 Q01959 1/20 0.41
IDH1 O75874 1/20 0.38
HSD17B10 Q99714 5/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846224 0.81 PARP1 (0.46) KCNH2PARP1KDM4ETSHRALDH1A1
SCHEMBL5047640 0.81 MPO (0.36) KCNH2PARP1KDM4EMPOSLC6A2
SCHEMBL5047668 0.80 HSD17B10 (0.35) KCNH2PARP1KDM4ETSHRSLC6A2
SCHEMBL3847249 0.79 HRH4 (0.42) KCNH2PARP1DAODDOKDM4E
SCHEMBL5050024 0.79 MPO (0.35) KCNH2PARP1KDM4EMPOSLC6A2
SCHEMBL5050047 0.76 KCNH2 (0.35) KCNH2PARP1KDM4EMPOSLC6A2
SCHEMBL3844281 0.76 PARP1 (0.37) PARP1DAODDOKDM4EMPO
SCHEMBL27495582 0.73 HTR2A (0.58) KCNH2KDM4ESMN1; SMN2HTR2AHTR2C
SCHEMBL4425832 0.73 DAO (0.55) DAODDOKDM4ETSHRPKM
SCHEMBL5047576 0.72 EGLN1 (0.37) KCNH2PARP1DAODDOSLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044077-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES Glaxo Group Limited (GB) 2009-04-08 EP disclosed
EP-1893599-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2008009700-A1 DERIVATIVES AND ANALOGS OF N-ETHYLQUINOLONES AND N-ETHYLAZAQUINOLONES GLAXO GROUP LIMITED (GB) 2008-01-24 WO disclosed
WO-2006134378-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2006-12-21 WO disclosed